Status
Conditions
Treatments
About
To evaluate the management of HIV-1 participants treated with antiretroviral combination therapy including the integrase inhibitor raltegravir, all across the country of France.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
482 participants in 1 patient group
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal